You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
McKesson
Medtronic
AstraZeneca
Johnson and Johnson

Last Updated: February 25, 2020

DrugPatentWatch Database Preview

POSITIVE SKIN TEST CONTROL - HISTAMINE Drug Profile


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for POSITIVE SKIN TEST CONTROL - HISTAMINE

Identify potential brand extensions & biosimilar entrants

SponsorPhase
KeraNetics, LLCN/A
State University of New York - Downstate Medical CenterPhase 2
Conselho Nacional de Desenvolvimento Científico e TecnológicoPhase 3

See all POSITIVE SKIN TEST CONTROL - HISTAMINE clinical trials

Recent Litigation for POSITIVE SKIN TEST CONTROL - HISTAMINE

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Ackerman v. Given2019-10-18
SHIONOGI INC. v. ZYDUS PHARMACEUTICALS (USA) INC.2018-08-16
Bayer HealthCare Pharmaceuticals Inc. v. Perrigo UK FINCO Limited Partnership2018-02-15

See all POSITIVE SKIN TEST CONTROL - HISTAMINE litigation

PTAB Litigation
PetitionerDate
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC2020-01-31
2018-05-25
2017-02-02

See all POSITIVE SKIN TEST CONTROL - HISTAMINE litigation

Patent Text Search: US Patents for POSITIVE SKIN TEST CONTROL - HISTAMINE

These patents were identified by searching patent claims

Supplementary Protection Certificates for POSITIVE SKIN TEST CONTROL - HISTAMINE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2004/009 Ireland   Start Trial PRODUCT NAME: RUPATADINE AND SALTS AND SOLVATES THEREOF, INCLUDING RUPATADINE FUMARATE; NAT REGISTRATION NO/DATE: 1129/1/1 20040109; FIRST REGISTRATION NO/DATE: ES 64063 20010704; PAEDIATRIC INVESTIGATION PLAN: P/0193/2013
175 5006-2013 Slovakia   Start Trial PRODUCT NAME: AZELASTIN ALEBO JEHO FARMACEUTICKY PRIJATE LNE SOLI A FARMACEUTICKY PRIJATEL NY ESTER FLUTIKAZONU; REGISTRATION NO/DATE: 24/0055/13-S 20130215
PA2013023 Lithuania   Start Trial PRODUCT NAME: AZELASTINUM HYDROCHLORICUM + FLUTICASONUM PROPIONICUM; REGISTRATION NO/DATE: LT/1/13/3227/001 - LT/1 3/3227/004
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Moodys
Mallinckrodt
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.